Variant report
Variant | nsv435816 |
---|---|
Chromosome Location | chr5:151455702-151462573 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:151454167..151456163-chr5:151462520..151465246,3 | K562 | blood: | |
2 | chr5:151454167..151456163-chr5:151462520..151465246,3 | K562 | blood: | |
3 | chr5:151455699..151457769-chr5:151461152..151464254,4 | MCF-7 | breast: | |
4 | chr5:151455898..151457873-chr5:151461230..151462733,2 | K562 | blood: | |
5 | chr5:151455898..151457873-chr5:151461230..151462733,2 | K562 | blood: | |
6 | chr5:151455699..151457769-chr5:151461152..151464254,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79532897 | chr5:151455762-151455763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561782742 | chr5:151455785-151455786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369302577 | chr5:151455786-151455787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs147075650 | chr5:151455807-151455808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs154696 | chr5:151455843-151455844 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs376250202 | chr5:151455902-151455903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533115162 | chr5:151455910-151455911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4484411 | chr5:151455927-151455928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551548212 | chr5:151455939-151455940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183171789 | chr5:151455974-151455975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373826101 | chr5:151455980-151455981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs160037 | chr5:151455990-151455991 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs549827067 | chr5:151456015-151456016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568245713 | chr5:151456113-151456114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535150025 | chr5:151456115-151456116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187628819 | chr5:151456134-151456135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138299028 | chr5:151456135-151456136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76734642 | chr5:151456156-151456157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs160036 | chr5:151456198-151456199 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs116984515 | chr5:151456220-151456221 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576676477 | chr5:151456248-151456249 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
22 | rs154695 | chr5:151456270-151456271 | Flanking Bivalent TSS/Enh | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs190653600 | chr5:151456277-151456278 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369503072 | chr5:151456301-151456302 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201687335 | chr5:151456320-151456321 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149638273 | chr5:151456329-151456330 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
27 | rs154694 | chr5:151456332-151456333 | Flanking Bivalent TSS/Enh | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs143411499 | chr5:151456343-151456344 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
29 | rs177439 | chr5:151456352-151456353 | Flanking Bivalent TSS/Enh | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs542041279 | chr5:151456400-151456401 | Flanking Bivalent TSS/Enh Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368520130 | chr5:151456429-151456430 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199837864 | chr5:151456431-151456432 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200704122 | chr5:151456432-151456433 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Parkinson disease | 21829596 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:151455400-151456200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:151456000-151456200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr5:151456200-151456400 | Flanking Bivalent TSS/Enh | HUES64 Cell Line | embryonic stem cell |
4 | chr5:151456400-151456600 | Active TSS | HUES64 Cell Line | embryonic stem cell |